Title:
抗ソルチリン抗体及びその使用方法
Document Type and Number:
Japanese Patent JP7208157
Kind Code:
B2
Abstract:
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured, humanized antibodies, antibody fragments, etc., that specifically bind a Sortilin protein, e.g., human Sortilin or mammalian Sortilin, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
Inventors:
Schwarb, Tina
Kurneras, Michael
Rosenthal, Arnon
Péjart, Robert
Cooper, Anthony Bee.
Kurneras, Michael
Rosenthal, Arnon
Péjart, Robert
Cooper, Anthony Bee.
Application Number:
JP2019559056A
Publication Date:
January 18, 2023
Filing Date:
July 12, 2019
Export Citation:
Assignee:
Alexandr Elsie
International Classes:
C07K16/28; A61K39/395; A61P9/00; A61P19/02; A61P21/00; A61P21/02; A61P25/00; A61P25/16; A61P25/28; A61P27/02; A61P27/06; A61P29/00; A61P31/04; C07K16/46; C12P21/08
Domestic Patent References:
| JP2018517401A |
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office